CPT® Code 80336

1. Indications

The laboratory test represented by CPT® Code 80336 is indicated for the measurement of tricyclic and other cyclic antidepressants in patients who may be undergoing treatment for various psychiatric and medical conditions. The specific indications for this test include:

• Depression: Patients diagnosed with major depressive disorder or other depressive disorders may require monitoring of their antidepressant levels to ensure therapeutic efficacy and safety.
• Anxiety Disorders: Individuals suffering from anxiety disorders may be prescribed TCAs or TeCAs, necessitating regular testing to manage their treatment effectively.
• Fibromyalgia: Patients with fibromyalgia may be treated with these antidepressants to alleviate pain and improve overall quality of life, warranting monitoring of drug levels.
• Chronic Pain: Chronic pain management may involve the use of tricyclic antidepressants, making it essential to assess their levels for optimal therapeutic outcomes.
• Bedwetting: In pediatric cases, TCAs may be prescribed to manage nocturnal enuresis (bedwetting), requiring testing to ensure appropriate dosing.

2. Procedure

The procedure for conducting the laboratory test under CPT® Code 80336 involves several key steps, which are detailed as follows:

• Step 1: Sample Collection - The first step in the procedure is the collection of biological samples. A blood sample is obtained through venipuncture, which is a standard method for drawing blood from a vein. Alternatively, a urine sample can be collected either by random voiding, where the patient simply urinates into a container, or through catheterization, which involves inserting a catheter into the bladder to obtain urine directly.
• Step 2: Sample Preparation - Once the samples are collected, they are prepared for analysis. This may involve processes such as centrifugation for serum or plasma samples to separate the liquid portion from the cellular components, ensuring that the samples are suitable for testing.
• Step 3: Analytical Testing - The prepared samples are then subjected to various analytical testing methods. For tricyclic antidepressants, quantitative liquid chromatography-tandem mass spectrometry is employed to accurately measure the levels of these compounds in urine, serum, or plasma. For the tetracyclic antidepressant loxapine, high-performance liquid chromatography is utilized. Amoxapine is tested using quantitative high-performance liquid chromatography, while maprotiline levels are assessed through quantitative gas chromatography. Lastly, mirtazapine is analyzed using both quantitative gas chromatography and gas chromatography-mass spectrometry.
• Step 4: Result Interpretation - After the testing is completed, the results are interpreted by qualified laboratory personnel. The levels of the antidepressants are compared against established therapeutic ranges to determine if the patient is within the appropriate dosing parameters.

3. Post-Procedure

Post-procedure care following the laboratory test for CPT® Code 80336 typically involves monitoring the patient for any potential side effects or adverse reactions related to the antidepressants being tested. Patients may be advised to follow up with their healthcare provider to discuss the test results and any necessary adjustments to their medication regimen. It is also important for healthcare providers to ensure that patients understand the significance of the test results in relation to their treatment plan, including any implications for dosage adjustments or changes in therapy. Regular monitoring may be recommended to maintain therapeutic effectiveness and minimize the risk of toxicity or side effects associated with tricyclic and tetracyclic antidepressants.